Global Research and Vaccine Development Collaboration
Partnering with institutions like Chulalongkorn University, the University of Pennsylvania, and CEPI, BioNet has leveraged DNA and mRNA platforms to develop COVID-19 vaccines and is now driving next-generation mRNA vaccines, including a pancoronavirus candidate.
Technology Transfer and Manufacturing Partnerships
We provide technology transfer solutions for vaccines like recombinant pertussis, Hib, HBV, and HPV, while collaborating with global manufacturers to produce bulk supplies and formulations for polio, rabies, influenza, hepatitis, and DTP vaccines.
Marketing & Distribution Network
BioNet has established a global marketing and distribution network, partnering with distributors, governments, NGOs, and vaccine manufacturers. Leveraging our expertise, we facilitate market access, streamline regulatory approvals, and enhance the global reach of licensed vaccines.
BioNet collaborates with first-class biopharmaceutical companies
and academic organizations around the globe.
